# Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia

> **NCT03865290** · PHASE2 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 150 (estimated)

## Conditions studied

- Indigestion
- Diabetes Mellitus

## Interventions

- **DRUG:** Ondansetron 8mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03865290
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-04-02
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03865290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03865290, "Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03865290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*